Due to atypical binding properties described for CBRs expressed in cancer cell lines thus far, qRT-PCR was next employed to determine whether mRNA for canonical CB1 and/or CB2 receptors was detectable in cancer cells (Figure 2C). Here, CNR1 is linked to cancer.